Vanguard Group’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
|
|||||
2024
Q1 | $166K | Sell |
|
|||||
2023
Q4 | $395K | Buy |
|
|||||
2023
Q3 | $952K | Buy |
|
|||||
2023
Q2 | $5.97M | Sell |
|
|||||
2023
Q1 | $3.47M | Hold |
|
|||||
2022
Q4 | $3.41M | Hold |
|
|||||
2022
Q3 | $5.16M | Buy |
|
|||||
2022
Q2 | $3.35M | Sell |
|
|||||
2022
Q1 | $4.74M | Buy |
|
|||||
2021
Q4 | $8.39M | Sell |
|
|||||
2021
Q3 | $12.5M | Buy |
|
|||||
2021
Q2 | $12.7M | Buy |
|
|||||
2021
Q1 | $14.6M | Buy |
|
|||||
2020
Q4 | $4.42M | Buy |
|
|||||
2020
Q3 | $461K | Buy |
|
|||||
2020
Q2 | $305K | Sell |
|
|||||
2020
Q1 | $158K | Buy |
|
|||||
2019
Q4 | $321K | Hold |
|
|||||
2019
Q3 | $220K | Hold |
|
|||||
2019
Q2 | $524K | Buy |
|
|||||
2019
Q1 | $394K | Buy |
|
|||||
2018
Q4 | $33K | Sell |
|
|||||
2018
Q3 | $70K | Sell |
|
|||||
2018
Q2 | $127K | Sell |
|
|||||
2018
Q1 | $189K | Buy |
|
|||||
2017
Q4 | $541K | Hold |
|
|||||
2017
Q3 | $620K | Buy |
|
|||||
2017
Q2 | $316K | Sell |
|
|||||
2017
Q1 | $720K | Buy |
|
|||||
2016
Q4 | $206K | Hold |
|
|||||
2016
Q3 | $473K | Hold |
|
|||||
2016
Q2 | $604K | Hold |
|
|||||
2016
Q1 | $872K | Hold |
|
|||||
2015
Q4 | $1.43M | Hold |
|
|||||
2015
Q3 | $2.16M | Hold |
|
|||||
2015
Q2 | $2.24M | Hold |
|
|||||
2015
Q1 | $2.4M | Hold |
|
|||||
2014
Q4 | $1.15M | Hold |
|
|||||
2014
Q3 | $1.72M | Hold |
|
|||||
2014
Q2 | $2.52M | Hold |
|
|||||
2014
Q1 | $2.41M | Hold |
|
|||||
2013
Q4 | $2.43M | Hold |
|
|||||
2013
Q3 | $1.9M | Hold |
|
|||||
2013
Q2 | $2.04M | Buy |
|